These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20335186)

  • 21. Prognostic factors for nosocomial bacteraemia outcome: a prospective study in a Greek teaching hospital.
    Arvanitidou M; Katikaridou E; Douboyas J; Tsakris A
    J Hosp Infect; 2005 Nov; 61(3):219-24. PubMed ID: 16039015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology and susceptibility to antimicrobials in community, hospital and long-term care facility bacteremia in northern Israel: a 6 year surveillance.
    Chazan B; Raz R; Teitler N; Nitzan O; Edelstein H; Colodner R
    Isr Med Assoc J; 2009 Oct; 11(10):592-7. PubMed ID: 20077944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
    Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
    Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
    Erlandson KM; Sun J; Iwen PC; Rupp ME
    Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series.
    Fowler S; Webber A; Cooper BS; Phimister A; Price K; Carter Y; Kibbler CC; Simpson AJ; Stone SP
    J Antimicrob Chemother; 2007 May; 59(5):990-5. PubMed ID: 17387117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic therapy for gram-negative bacteremia.
    Calandra T; Cometta A
    Infect Dis Clin North Am; 1991 Dec; 5(4):817-34. PubMed ID: 1783770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.
    Yu VL; Chiou CC; Feldman C; Ortqvist A; Rello J; Morris AJ; Baddour LM; Luna CM; Snydman DR; Ip M; Ko WC; Chedid MB; Andremont A; Klugman KP;
    Clin Infect Dis; 2003 Jul; 37(2):230-7. PubMed ID: 12856216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse.
    Leone M; Garcin F; Bouvenot J; Boyadjev I; Visintini P; Albanèse J; Martin C
    Crit Care Med; 2007 Feb; 35(2):379-85; quizz 386. PubMed ID: 17205011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients.
    Chelliah A; Heydon KH; Zaoutis TE; Rettig SL; Dominguez TE; Lin R; Patil S; Feudtner C; St John KH; Bell LM; Coffin SE
    Pediatr Infect Dis J; 2007 Sep; 26(9):816-20. PubMed ID: 17721377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy.
    Falagas ME; Kasiakou SK; Rafailidis PI; Zouglakis G; Morfou P
    J Antimicrob Chemother; 2006 Jun; 57(6):1251-4. PubMed ID: 16627593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey.
    Erbay A; Bodur H; Akinci E; Colpan A
    J Hosp Infect; 2005 Jan; 59(1):53-61. PubMed ID: 15571854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.
    Schouten JA; Hulscher ME; Trap-Liefers J; Akkermans RP; Kullberg BJ; Grol RP; van der Meer JW
    Clin Infect Dis; 2007 Apr; 44(7):931-41. PubMed ID: 17342644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
    Ruotsalainen E; Järvinen A; Koivula I; Kauma H; Rintala E; Lumio J; Kotilainen P; Vaara M; Nikoskelainen J; Valtonen V;
    J Intern Med; 2006 Feb; 259(2):179-90. PubMed ID: 16420547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
    Shorr AF; Combes A; Kollef MH; Chastre J
    Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia.
    Byl B; Clevenbergh P; Jacobs F; Struelens MJ; Zech F; Kentos A; Thys JP
    Clin Infect Dis; 1999 Jul; 29(1):60-6; discussion 67-8. PubMed ID: 10433566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
    Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
    Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic treatment duration for bloodstream infections in critically ill patients: a national survey of Canadian infectious diseases and critical care specialists.
    Daneman N; Shore K; Pinto R; Fowler R
    Int J Antimicrob Agents; 2011 Dec; 38(6):480-5. PubMed ID: 21982833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.